Mitsubishi Chemical Holdings Corporation

04/11/2022 | Press release | Distributed by Public on 04/11/2022 01:05

Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355)NEW

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.